Price T Rowe Associates Inc Amphastar Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 541,221 shares of AMPH stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
541,221
Previous 566,656
4.49%
Holding current value
$13.9 Million
Previous $21 Million
25.43%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$153 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$62.3 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$56.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.9 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.26B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...